Neutrophil-to-lymphocyte ratio (NLR) during induction is a better predictor than preoperative NLR in non-muscle-invasive bladder cancer receiving Bacillus Calmette-GuERin

被引：7
|
作者：
Li, Deng-xiong [1 ]
Wang, Xiao-ming [1 ]
Feng, De-chao [1 ]
Han, Ping [1 ,2 ]
机构：
[1] Sichuan Univ, West China Hosp, Inst Urol, Dept Urol, Chengdu 610041, Sichuan Provinc, Peoples R China
[2] Sichuan Univ, West China Hosp, Inst Urol, Dept Urol, Guoxue Xiang 37, Chengdu 610041, Sichuan Provinc, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2023年 / 46卷 / 03期
关键词：
Non-muscle-invasive bladder cancer; Bacillus Calmette-Gue ?rin; Neutrophil-to-lymphocyte ratio;
D O I：
10.1016/j.asjsur.2022.08.108
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：1348 / 1351
页数：4
相关论文
共 50 条
  • [41] Bacillus Calmette-Guerin unresponsiveness in non-muscle-invasive bladder cancer patients: what the urologists should know
    Moschini, Marco
    Zamboni, Stefania
    Mattei, Agostino
    Amparore, Daniele
    Fiori, Cristian
    De Dominicis, Carlo
    Esperto, Francesco
    MINERVA UROLOGICA E NEFROLOGICA, 2019, 71 (01) : 17 - 30
  • [42] Intravesical bacillus Calmette-Guerin versus chemohyperthermia for high-risk non-muscle-invasive bladder cancer
    Ekin, Rahmi Gokhan
    Akarken, Ilker
    Zorlu, Ferruh
    Tarhan, Huseyin
    Kucuk, Ulku
    Yildirim, Zubeyde
    Divrik, Rauf Taner
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2015, 9 (5-6): : E278 - E283
  • [43] Bacillus Calmette-Guerin Without Maintenance Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer
    Herr, Harry W.
    Dalbagni, Guido
    Donat, Sherri M.
    EUROPEAN UROLOGY, 2011, 60 (01) : 32 - 36
  • [44] Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guerin Immunotherapy
    Bacon, Jack V. W.
    Muller, David C.
    Ritch, Elie
    Annala, Matti
    Dugas, Sarah G.
    Herberts, Cameron
    Vandekerkhove, Gillian
    Seifert, Helge
    Zellweger, Tobias
    Black, Peter C.
    Bubendorf, Lukas
    Wyatt, Alexander W.
    Rentsch, Cyrill A.
    EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (06): : 677 - 686
  • [45] Pyuria predicts poor prognosis in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin
    Azuma, Takeshi
    Nagase, Yasushi
    Oshi, Masaya
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (05) : 1113 - 1116
  • [46] Salvage Therapies for Non-muscle-invasive Bladder Cancer: Who Will Respond to Bacillus Calmette-Guerin? Predictors and Nomograms
    Faba, Oscar Rodriguez
    Pisano, Francesca
    Krajewski, Wojciech
    Breda, Alberto
    Palou, Joan
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (01) : 5 - 13
  • [47] Efficacy and toxicity of intravesical Bacillus Calmette-Guerin therapy in elderly patients with non-muscle-invasive bladder cancer
    Matsuoka, Yuki
    Taoka, Rikiya
    Kohashiguchi, Kana
    Tohi, Yoichiro
    Miyauchi, Yasuyuki
    Kato, Takuma
    Tsunemori, Hiroyuki
    Ueda, Nobufumi
    Sugimoto, Mikio
    CURRENT UROLOGY, 2021, 15 (01) : 16 - 21
  • [48] Predictive biomarkers of response to bacillus Calmette-Guerin immunotherapy and bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer
    Wang, Ziting
    So, Wei Zheng
    Loh, Kep Yong
    Lim, Yew Koon
    Mahendran, Ratha
    Wu, Qing Hui
    Chiong, Edmund
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (08) : 807 - 815
  • [49] Evaluation of sarcopenia in patients receiving intravesical Bacillus Calmette-Guerin for non-muscle invasive bladder cancer
    Alam, Syed M.
    Larson, Matthew
    Srinivasan, Pugazhendhi
    Genz, Nick
    Fleer, Ryan
    Sardiu, Mihaela
    Thompson, Jeffrey
    Lee, Eugene
    Hamilton-Reeves, Jill
    Wulff-Burchfield, Elizabeth
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (10) : 431.e15 - 431.e20
  • [50] Preoperative neutrophil-to-lymphocyte ratio (NLR) may be predictive of pathologic stage in patients with bladder cancer larger than 3 cm
    Celik, O.
    Akand, M.
    Keskin, M. Z.
    Yoldas, M.
    Ilbey, Y. O.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (04) : 652 - 656
12345